Curriculum Vitae

DR. MOHD DANISH ANSARI

Lecturer
  • Department of Pharmaceutical Technology
    Faculty of Pharmacy
  • drmohddanish
  • 03-79677022

BIOGRAPHY

Dr. Mohd Danish Ansari is an academician and researcher specializing in pharmaceutics, pharmaceutical nanotechnology, and advanced drug delivery systems. He currently serves as a lecturer at the Dept. of Pharmaceutical Technology, Faculty of Pharmacy, University of Malaya, Kuala Lumpur, Malaysia. His teaching portfolio spans pharmaceutical engineering, industrial pharmacy, novel drug delivery systems, pharmaceutical analysis, regulatory affairs, and dosage form design at both undergraduate and postgraduate levels. He also holds several academic leadership roles, including Course Coordinator (Quality Assurance), Head of the Certification Unit, member of the Universiti Malaya Research Ethics Committee (UMREC), Accreditation Task Force member, and Final Year Project (FYP) Coordinator. He actively contributes as a postgraduate thesis evaluator, PhD examiner, and academic administrator.

Dr. Ansari earned his Ph.D. in Pharmaceutics from Jamia Hamdard, where his doctoral research focused on the development of novel vesicular spanlastic systems for enhancing the bioavailability of BCS Class II drugs via the transdermal route. He also completed his M.Pharm, B.Pharm, and D.Pharm from the same institution. His research interests include pharmaceutical nanotechnology, transdermal and targeted drug delivery, biomaterials, hydrogels, lipid and polymeric nanoparticles, nanomedicine, pharmacokinetics and pharmacodynamics, and regulatory sciences.

In addition to academia, Dr. Ansari has professional experience as an associate scientific writer at leading life sciences consulting organizations, where he contributed to manuscript preparation, regulatory writing, medical information development, instructional design, data analytics, and scientific communications. Earlier in his career, he served as a lecturer in pharmaceutics and worked as a project assistant under a DST Nano Mission-funded project of the government of India, focusing on the formulation and in vivo evaluation of nanoemulsion-based drug delivery systems for osteoporosis management.

Dr. Ansari is a GPAT-qualified professional and recipient of multiple Best Publication Awards for high-impact research contributions. His scholarly work reflects a strong commitment to innovation in nanomedicine and translational pharmaceutical research. Dr. Ansari has authored over 25 high-impact publications in Q1–Q3 journals, including pioneering work on nanospanlastics, lipid-polymer hybrid nanoparticles, SNEDDS, and nanoengineered delivery systems for neurological disorders, osteoporosis, and cancer. He has contributed book chapters on nanostructured drug carriers and fixed-dose combination techniques. His research has been recognized internationally, and he has presented at multiple conferences, receiving awards for oral presentations. His publications demonstrate a strong translational focus, bridging innovative nanotechnology with patient-centered therapeutic applications.

Dr. Ansari serves as a peer reviewer for several national and international journals. His expertise in pharmaceutics, nanotechnology, and drug delivery enables him to critically evaluate manuscripts and contribute to maintaining high scientific standards in these publications.

 

ACADEMIC QUALIFICATION

  • PhD (PHARMACEUTICS), ((PHARMACEUTICS))
    Jamia Hamdard
  • MASTER OF PHARMACY (PHARMACEUTICS), (PHARMACEUTICS)
    Jamia Hamdard
  • BACHELOR OF PHARMACY, (Pharmacy)
    Jamia Hamdard
  • DIPLOMA IN PHARMACY, (Pharmacy)
    Jamia Hamdard

WORKING EXPERIENCE

  • 15 Mar 2021 -
    26 Jun 2022-
    Lecturer
    Jamia Hmadard, New Delhi, India
  • 17 Oct 2018 -
    28 Feb 2021-
    Research Assistant
    Department Science and Technology Government of India

ADMINISTRATIVE DUTIES

  • Committee Members
    13 Oct 2025 - 12 Oct 2027 (University Malaya)
  • Head of the Certification Unit, Faculty of pharmacy
    03 Feb 2025 - 30 Oct 2026 (Department of Pharmaceutical Technology, Faculty of Pharmacy)
  • Member of the Universiti Malaya Research Ethics Committee (UMREC)
    20 Oct 2025 - 30 Oct 2026 (University Malaya)
  • Accreditation task force member
    08 Jan 2026 - 30 Oct 2026 (Department of Pharmaceutical Technology, Faculty of Pharmacy)
  • Coordinator of the Final year project (FYP)
    12 Feb 2026 - 30 Oct 2026 (Department of Pharmaceutical Technology, Faculty of Pharmacy)
  • Committee Members
    28 Aug 2025 - 27 Aug 2026 (Department)
  • Course Coordinator
    17 Oct 2025 - 13 Jan 2026 (Department)

AWARD AND STEWARDSHIP

  • Best Publication Award
    2023, Jamia Hamdard University, New Delhi, India, University
  • Best Publication Award
    2022, Jamia Hmadard University, New Delhi India, University

PUBLICATIONS

Article in Journal
WoS
  1. Ansari, Mohd. Danish; Majid, Haya; Mahmood, Syed; Sofian, Zarif Mohamed; Husain, Asif; Sultana, Yasmin; Shakeel, Faiyaz (2026). Nanotechnology-enabled delivery of phytoconstituents: Recent developments, applications, and regulatory considerations, ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE. 16(1), 1-23. doi:10.4103/apjtb.apjtb_491_25
  2. Alawi, Marwa; Hilles, Ayah R.; Kumar, Mohit; Ansari, Mohd Danish; Mahmood, Syed (2025). Lipid-polymer hybrid nanoparticles: a cutting-edge frontier in breast cancer treatment strategies, NANOMEDICINE. 20(14), 1775-1798. doi:10.1080/17435889.2025.2523730
  3. Haidar, Md. Amanullah; Emad, Nasr A.; Ansari, Mohd. Danish; Ahmad, Saeem; Alam, Shadab; Yasmin, Saba; Saba, Nishat; Aqil, Mohd.; Sultana, Yasmin (2025). Optimized SNEDDS of Riluzole for Alzheimer's Disease: Enhancing Solubility, Bioavailability, and Therapeutic Efficacy in Scopolamine-induced Rats Model, JOURNAL OF CLUSTER SCIENCE. 36(5). doi:10.1007/s10876-025-02919-7
  4. Majid, Haya; Dahalia, Mansi; Ansari, Mohd. Danish; Jain, Seema; Samim, Mohammed; Nidhi (2025). Intranasal Liposomal Trimetazidine Nanocarriers Modulate Neuroinflammation and Neurotransmission via the HMGB1/TLR4/NF- B Pathway in an Experimental Epilepsy Model, MOLECULAR NEUROBIOLOGY. 63(1). doi:10.1007/s12035-025-05398-z
  5. Nadeem, Mohd; Majid, Haya; Ansari, Mohd Danish; Ahmad, Farhan Jalees; Parvez, Suhel; Akhtar, Mohd; Ahmad, Sayeed; Najmi, Abul Kalam (2025). Development and Optimization of Piracetam and Shatavarin IV-Loaded Nanoemulsion for Alzheimer's Disease Therapy: In Silico and Experimental Analysis, ACS OMEGA. 10(9), 9132-9153. doi:10.1021/acsomega.4c09072
  6. Shahreen, Nekhat; Agnihotri, Anukrati; Rizwan, Asfi; Hasan, Faizul; Ansari, Mohd Danish; Sofian, Zarif Mohamed; Said, Nur Akmarina B. M.; To, Kenneth K. W.; Mahmood, Syed (2025). Nanoengineered-based delivery systems to modulate CD4+ T cell responses in cancer: emerging paradigms in cancer immunotherapy, FRONTIERS IN PHARMACOLOGY. 16. doi:10.3389/fphar.2025.1643791
  7. Biswas, Avirup; Mathew, A. Jesil; Lewis, Shaila Angela; Raja, Selvaraj; Paul, Arpita; Ghosal, Kajal; Mahmood, Syed; Ansari, Mohd Danish (2024). Design and Evaluation of Microemulsion-Based Drug Delivery Systems for Biofilm-Based Infection in Burns, AAPS PHARMSCITECH. 25(7). doi:10.1208/s12249-024-02909-4
  8. Ahmed, S., Mahmood, S., Ansari, M. D., Gull, A., Sharma, N., & Sultana, Y. (2021). Nanostructured lipid carrier to overcome stratum corneum barrier for the delivery of agomelatine in rat brain; formula optimization, characterization and brain distribution study. International Journal of Pharmaceutics, 607, 13. doi: 10.1016/j.ijpharm.2021.121006
Scopus
  1. Nadeem M., Majid H., Ansari M.D., Ahmad F.J., Parvez S., Akhtar M., Ahmad S., Najmi A.K. (2025). Development and Optimization of Piracetam and Shatavarin IV-Loaded Nanoemulsion for Alzheimer s Disease Therapy: In Silico and Experimental Analysis, ACS Omega. . doi:10.1021/acsomega.4c09072
Others
  1. Alam, A., Imran, M., Ansari, M. D., & Elkirdasy, A. F. (2024). Preparation of Aloysia citriodora (Lemon verbena) extract loaded lipid-nano capsules for topical antibacterial treatment. Journal of Drug Delivery Science and Technology, 101, 106164.
  2. Ansari, M. D., Shafi, S., Pandit, J., Waheed, A., Jahan, R. N., Khan, I., ... & Sultana, Y. (2024). Raloxifene encapsulated spanlastic nanogel for the prevention of bone fracture risk via transdermal administration: Pharmacokinetic and efficacy study in animal model. Drug Delivery and Translational Research, 14(6), 1635-1647.
  3. Ansari, M. D., Majid, H., Khan, A., & Sultana, Y. (2023). Clinical frontiers of metabolic bone disorders: a comprehensive review. Metabolism and Target Organ Damage, 4(1), N-A.
  4. Ansari, M. D., Solanki, P., Pandit, J., Jahan, R. N., Aqil, M., & Sultana, Y. (2022). Fabrication and optimization of raloxifene loaded spanlastics vesicle for transdermal delivery. Journal of Drug Delivery Science and Technology, 68, 103102.
  5. Brain targeted delivery of carmustine using chitosan coated nanoparticles via nasal route for glioblastoma treatment
  6. Formulation and development of Pam-PLc complex loaded self nano-emulsifying drug delivery system (SNEDDS) for the treatment of osteoporosis
  7. Khan, I., Pandit, J., Ahmed, S., Zameer, S., Ahmad, S., Bano, S., ... & Sultana, Y. (2022). Development and evaluation of biodegradable polymeric lomustine nanofibres for the efficient tumor targeting: In vitro characterization, ex vivo permeation and degradation study. Journal of Drug Delivery Science and Technology, 75, 103685.
  8. Solanki, P., Ansari, M. D., Alam, M. I., Aqil, M., Ahmad, F. J., & Sultana, Y. (2023). Precision engineering designed phospholipid-tagged pamidronate complex functionalized SNEDDS for the treatment of postmenopausal osteoporosis. Drug Delivery and Translational Research, 13(3), 883-913.
  9. Spanlastics a novel nanovesicular carrier: Its potential application and emerging trends in therapeutic delivery
  10. Solanki, P., Ansari, D., & Sultana, Y. (2022). Nanostructured carrageenan as drug carrier. Nanoengineering of Biomaterials, 523-542.
  11. Solanki, P., Ansari, M. D., Khan, I., Jahan, R. N., Pandit, J., Aqil, M., ... & Sultana, Y. (2021). Repurposing pentosan polysulfate sodium as hyaluronic acid linked polyion complex nanoparticles for the management of osteoarthritis: a potential approach. Medical Hypotheses, 157, 110713.
  12. Ahmed, S., Gull, A., Aqil, M., Ansari, M. D., & Sultana, Y. (2019). Poloxamer-407 thickened lipid colloidal system of agomelatine for brain targeting: Characterization, brain pharmacokinetic study and behavioral study on Wistar rats. Colloids and Surfaces B: Biointerfaces, 181, 426-436.
  13. Ansari, M. D., Ahmed, S., Imam, S. S., Khan, I., Singhal, S., Sharma, M., & Sultana, Y. (2019). CCD based development and characterization of nano-transethosome to augment the antidepressant effect of agomelatine on Swiss albino mice. Journal of Drug Delivery Science and Technology, 54, 101234.
Chapter in Books
  1. Ansari, M. D., Majid, H., Aqil, M., & Sultana, Y. (2026). Fixed-dose combination techniques in ophthalmic products. In Ophthalmic Drug Delivery (pp. 83-110). Academic Press.

RESEARCH PROJECT

University
  1. 2025 - 2027, Bantuan Khas Penyelidikan (BKP Special)
    Formulation, Characterization, and In Vitro Evaluation of Limonene-Based Imeglimin-Loaded Transethosomes for Improved Anti-Diabetic Efficacy ( Principal Investigator(PI))

ACADEMIC/ PROF. SERVICES

Evaluation
  1. (2025) Exploring The Potential of in Situ Hydrogels Incorporated With a Tissue Regenerative Tripeptide and a Natural Carotenoid for Diabetic Wound Healing, University, (Internal Examiner)
  2. (2025) Preparation, Characterization, and Ex Vivo Mucoadhesive Studies of Triamcinolone Acetonide-impregnated Chitosan/plga Nanocomposite Buccal Film for Oral Mucosa Ulcer, International, (Reviewer)
  3. (2025) Synthesis, Characterization and Ex Vivo Studies of Layer Coated Liposomes Infused in Dissolvable Microneedle Packed in Capsule for Oral Delivery of Insulin, University, (Internal Examiner)
  4. (2025) Study of Progress a Theoretical Framework for Optimal Medication Delivery Via Transdermal Drug Delivery System With Stakeholder Feedback, University, (Internal Examiner)
  5. (2025) Ultrastructural Study of The Effect of Ag Nanoparticles On The Helminth Heterakis Dispar in Vitro Condition, International, (Reviewer)
  6. (2025) Evaluation of Inhalable Polyamine-decorated Liposomal Dry Powders for Lung Cancer Therapy, University, (Internal Examiner)
  7. (2025) Isolation and Evaluation of Flavonoids from Propolis Against Triple-negative Breast Cancer Cells: Insights from Invitro and Insilico Studies, International, (Reviewer)
  8. (2025) Design, Synthesis and Evaluation of Folic Acid-decorated Chitosan-based Kaempferol and 5-fu Nanoparticles for Breast Cancer, University, (Internal Examiner)
  9. (2025) Formulation and Characterization of Polyherbal Topical Cream Preparation and Evaluation of Antioxidant and Anti- Ageing Activity Using Caenorhabditis Elegans., University, (Internal Examiner)

SUPERVISION

Under Graduate Students
  1. (2025) Preformulation Study and Quality by Design (QbD)-Driven Optimization of Valsartan-Loaded Nanospanlastics for Hypertension Management
  2. (2025) Nanoengineered-based delivery systems to modulate CD4+ T cell responses in cancer: emerging paradigms in cancer immunotherapy
Postgraduate Student
  1. (2024) Comparative Study of Drug Approval Timelines in Asean Countries, ZAAIN AHMED NASEEM

TEACHING

Full-Time Equivalent (FTE)
  1. (2026) OIA3023 - Extemporaneous Preparations
  2. (2026) OQA7003 - Quality Assurance
  3. (2026) OQA7007 - Pharmaceutical Analysis and Testing
  4. (2025) OQA7009 - Development of Novel Drug Delivery Systems